CDXS
CDXS
NASDAQ · Life Sciences Tools & Services

Codexis Inc

$1.78
+0.15 (+9.20%)
As of Apr 1, 3:00 PM ET ·
Financial Highlights (FY 2026)
Revenue
72.04M
Net Income
-45,008,759
Gross Margin
86.7%
Profit Margin
-62.5%
Rev Growth
-20.2%
D/E Ratio
0.79
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 86.7% 86.7% 54.9% 54.9%
Operating Margin -59.3% -53.4% 15.1% 14.1%
Profit Margin -62.5% -59.4% 11.9% 9.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 72.04M 90.30M 48.43M 53.29M
Gross Profit 62.48M 78.32M 26.58M 29.25M
Operating Income -42,722,294 -48,195,117 7.30M 7.53M
Net Income -45,008,759 -50,774,483 5.77M 5.06M
Gross Margin 86.7% 86.7% 54.9% 54.9%
Operating Margin -59.3% -53.4% 15.1% 14.1%
Profit Margin -62.5% -59.4% 11.9% 9.5%
Rev Growth -20.2% -20.2% +4.8% -3.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 32.17M 32.17M 36.68M 34.44M
Total Equity 40.53M 40.53M 50.40M 46.39M
D/E Ratio 0.79 0.79 0.73 0.74
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -42,430,969 -50,525,721 7.56M 9.74M
Free Cash Flow 6.31M 7.69M